American Century Companies Inc. Acquires 2,213 Shares of iRadimed Corporation $IRMD

American Century Companies Inc. raised its stake in iRadimed Corporation (NASDAQ:IRMD) by 13.8% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,284 shares of the medical equipment provider’s stock after buying an additional 2,213 shares during the quarter. American Century Companies Inc. owned about 0.14% of iRadimed worth $960,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. MetLife Investment Management LLC raised its holdings in shares of iRadimed by 11.4% during the fourth quarter. MetLife Investment Management LLC now owns 4,845 shares of the medical equipment provider’s stock worth $266,000 after acquiring an additional 494 shares during the period. Teacher Retirement System of Texas increased its holdings in iRadimed by 2.1% during the 1st quarter. Teacher Retirement System of Texas now owns 51,359 shares of the medical equipment provider’s stock worth $2,695,000 after purchasing an additional 1,072 shares in the last quarter. Envestnet Asset Management Inc. raised its stake in shares of iRadimed by 20.3% in the 1st quarter. Envestnet Asset Management Inc. now owns 70,473 shares of the medical equipment provider’s stock valued at $3,698,000 after purchasing an additional 11,892 shares during the period. Bank of America Corp DE lifted its holdings in shares of iRadimed by 8.1% in the fourth quarter. Bank of America Corp DE now owns 25,971 shares of the medical equipment provider’s stock valued at $1,428,000 after purchasing an additional 1,949 shares in the last quarter. Finally, Northern Trust Corp boosted its position in shares of iRadimed by 7.3% during the fourth quarter. Northern Trust Corp now owns 143,069 shares of the medical equipment provider’s stock worth $7,869,000 after buying an additional 9,722 shares during the period. Institutional investors own 92.34% of the company’s stock.

iRadimed Stock Performance

NASDAQ:IRMD opened at $70.60 on Thursday. The stock has a 50-day simple moving average of $64.51 and a 200 day simple moving average of $57.68. iRadimed Corporation has a 52-week low of $44.58 and a 52-week high of $74.00. The company has a market cap of $898.03 million, a PE ratio of 43.58 and a beta of 1.02.

iRadimed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Stockholders of record on Monday, August 18th were issued a $0.17 dividend. The ex-dividend date was Monday, August 18th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.0%. iRadimed’s dividend payout ratio (DPR) is 41.98%.

Insider Activity at iRadimed

In related news, Director Monty K. Allen sold 1,102 shares of the stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $69.10, for a total transaction of $76,148.20. Following the completion of the transaction, the director owned 19,898 shares in the company, valued at approximately $1,374,951.80. This represents a 5.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 36.80% of the stock is currently owned by corporate insiders.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.